Sofina — Private Equity & PMI Cycle

Sofina is a Belgian holding company with a 175-year history — controlling a portfolio of listed equities, private equity investments and fund commitments across consumer, technology, healthcare and education sectors globally. Controlled by the Boël family, Sofina's NAV tracks equity market cycles and private company valuations. The company has evolved from a traditional European industrial holding to a globally-diversified private equity and listed equity investor with significant exposure to fast-growing Asian and emerging market consumer companies.

NAV Cycle: Equity Market Sensitivity

Sofina's share price tracks its Net Asset Value — the sum of its portfolio holdings at market value. When global equity markets rise, Sofina's listed holdings appreciate and private company valuations increase (often marked-to-market on comparable multiples). When equity markets fall, NAV declines and Sofina often trades at a discount to NAV — creating a potential entry opportunity for patient investors who believe in the long-run portfolio quality.

Growth Equity: The Core Strategy

Sofina focuses on growth-stage companies — typically private businesses growing revenues at 20%+/year in education, consumer tech, healthcare and food/nutrition. Notable holdings include Byju's (Indian edtech), Meero (French photo tech) and various Asian consumer companies. Growth equity valuations are highly sensitive to interest rate environments — rising rates compress growth multiples significantly.

Geographic Diversification: Asia Focus

Sofina has built significant exposure to Asian growth markets — India, Southeast Asia, China — through both direct investments and fund commitments. This emerging market exposure provides diversification from European economic cycles but adds currency and political risk. Indian consumer market growth (middle-class expansion, digitalisation) is a key long-term thesis.

Family Control: Stability and Patience

The Boël family's controlling position (via Compagnie Nationale à Portefeuille) enables Sofina to pursue very long-term investment horizons — holding positions for decades rather than typical PE fund lifecycles. This patient capital approach has compounded NAV significantly over Sofina's 175-year history, but creates illiquidity in the private portfolio during downturns.

Cycle Performance Summary